Clinical Trial Update: A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms [Phase 4]

View source ↗

Summary

Phase 4 study evaluating whether DaTSCAN imaging changes clinical management in patients with clinically uncertain parkinsonism or similar symptoms; results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinsonism

Drugs mentioned

• DaTscan (ioflupane)

Snippet

Sponsor: GE Healthcare | Conditions: Parkinsonian Syndromes | Phase 4 | Status: COMPLETED | Results posted: 2012-08-29